Showing results (271-280 of 482) with videos related to

Sort By:
Pageof 49
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|February 12, 2024
Heavy metals in biological samples of cancer patients: a systematic literature reviewDonatella Coradduzza, Antonella Congiargiu, Emanuela Azara, et al.
Pathology, Research and Practice|March 30, 2013
Mutation analysis of KRAS in primary colorectal cancer and matched metastases by means of highly sensitivity molecular assayUmberto Miglio, Rosanna Mezzapelle, Alessia Paganotti, et al.
American Journal of Clinical Pathology|August 23, 2012
Epidermal growth factor receptor gene analysis with a highly sensitive molecular assay in routine cytologic specimens of lung adenocarcinomaSara Allegrini, Jlenia Antona, Rosanna Mezzapelle, et al.
Scientific Reports|November 2, 2023
Genome-wide epigenetic modifications in sports horses during training as an adaptation phenomenonKatia Cappelli, Samanta Mecocci, Andrea Porceddu, et al.
Medicina (Kaunas, Lithuania)|November 27, 2021
A Portrait of Intratumoral Genomic and Transcriptomic Heterogeneity at Single-Cell Level in Colorectal CancerAndrea Angius, Antonio Mario Scanu, Caterina Arru, et al.
Clinical Colorectal Cancer|January 21, 2018
LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test ResultMaria Teresa Rodia, Rossella Solmi, Francesco Pasini, et al.
Virchows Archiv : an International Journal of Pathology|October 28, 2008
Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20Gianluca Marucci, Luca Morandi, Elisabetta Magrini, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 28, 2008
High MUC2 immunohistochemical expression is a predictor of poor response to preoperative radiochemotherapy (RCT) in rectal adenocarcinomaAndrea Ambrosini-Spaltro, Fabrizio Salvi, Rossella Miglio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1992
An outpatient phase I study of a subcutaneous interleukin-2 and intramuscular alpha-2a-interferon combination in advanced malignanciesR Rosso, M R Sertoli, P Queirolo, et al.
Pageof 49